Nektar Therapeutics
NKTR
#5671
Rank
S$1.51 B
Marketcap
S$74.58
Share price
0.39%
Change (1 day)
267.03%
Change (1 year)

EPS for Nektar Therapeutics (NKTR)

EPS in 2025 (TTM): S-$5.56

According to Nektar Therapeutics 's latest financial reports the company's current EPS (TTM) is S-$5.49. In 2024 the company made an earnings per share (EPS) of S-$4.54 an increase over its 2023 EPS that were of S-$28.40.

EPS history for Nektar Therapeutics from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S-$5.5622.49%
2024S-$4.54-84.02%
2023S-$28.40-25.89%
2022S-$38.32-31.12%
2021S-$55.6414.86%
2020S-$48.44-1.19%
2019S-$49.02-163.96%
2018S$76.65-725.4%
2017S-$12.26-42.73%
2016S-$21.4083.33%
2015S-$11.6739.53%
2014S-$8.36-69.29%
2013S-$27.23-6.67%
2012S-$29.18

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Amgen
AMGN
S$16.90-408.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$2.23-140.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$9.85-279.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Richardson Electronics
RELL
S$0.01297-100.24%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$3.94-171.75%๐Ÿ‡ฌ๐Ÿ‡ง UK
Baxter
BAX
S-$0.86-84.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
S$2.68-148.94%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Johnson & Johnson
JNJ
S$13.54-346.79%๐Ÿ‡บ๐Ÿ‡ธ USA